Home Tags Dr. Darryl Glover

Tag: Dr. Darryl Glover

Optometry Trends 2026: New Treatments and Technology Including Stellest, Tryptyr, and...

As optometry moves into 2026, the profession is experiencing one of its most clinically rich and technologically diverse periods in recent memory. Reflecting on...

Mentorship in Optometry: A Guide for Optometry Students and Optometrists

Mentorship in optometry is one of the most influential forces shaping confident clinicians, strong leaders, and a sustainable future for the profession. Whether you are an experienced optometrist or an optometry student just beginning your journey, meaningful mentorship does not happen by chance—it is built through intention, trust, and follow-through.

Mindset, Metrics, and Meaningful Growth: How Dr. Fallon Patel Is Helping...

Dr. Patel makes a compelling case that practice growth is not a technology problem or a talent problem, but a mindset problem. The conversation moves beyond theory, arguing that without clear belief in personal value, intentional communication in the exam lane, and systems that turn KPIs into daily action, even the most clinically skilled practices will struggle to scale.

Top 10 Optometry Podcasts of 2025

Widely recognized as a #1 optometry podcast network, Defocus Media connects with practicing clinicians, industry leaders, and optometry students seeking clarity, education, and inspiration. Each optometrist podcast episode is designed to be approachable yet impactful, offering insights that can be applied in the exam lane, the optical, or beyond.

Leadership That Works: Applying the Working Genius Framework in Eye Care...

In this episode of The 2020 Podcast, host Dr. Harbir Sian welcomes leadership consultant Nancy Dewald for a thoughtful conversation on leadership, team effectiveness,...

Low-Dose Atropine Not FDA Approved: What the STAR Study Means for...

The topic of low-dose atropine, not FDA-approved, has become one of the most important conversations in pediatric eye care this year, especially as clinicians turn to the STAR Study for clarity on atropine’s role in modern myopia control. The STAR Study is the largest and most ethnically diverse atropine study to date, evaluating 0.01% and 0.03% atropine versus placebo in more than 800 children across three countries.

Top 4 Tips for Optometry Residency: Real Advice from a Current...

During this Defocus Media conversation, Dr. Darryl Glover sits down with Dr. Toby Wercberger, a vision therapy and rehabilitation resident at SUNY College of Optometry, to break down the realities of residency in a way that’s honest, practical, and student-focused.

Independent. Together. The Future of Independent Optometry with IDOC

Independent optometry flourishes when doctors have the freedom to practice on their own terms—without feeling like they’re doing it alone. That belief is at the core of IDOC’s brand refresh, “Independent. Together.” In a recent Defocus Media conversation, hosts Dr. Darryl Glover and Dr. Jenn Lyerly spoke with Dave Brown, CEO of IDOC (Independent Doctors of Optometric Care), about the organization’s 25-year journey. Brown shared how IDOC’s unified brand, robust data tools, and comprehensive business services are helping private practice optometry become stronger, more connected, and better positioned for long-term growth.

Optometry Student to New Grad: Mentorship, Mental Health, and Patient Connection...

In a conversation with Dr. Darryl Glover, new graduate Dr. Svetlana Nunez traced a path from early inspiration to her first steps as an optometrist—highlighting family support, the realities of training, and the habits that sustain mental well-being. This companion article distills her story into practical guidance for clinics and classrooms alike, focusing on optometry student mental health, the experience of a first-generation optometrist, and everyday patient communication that builds trust and inspires the next generation

Strengthening the Retina Referral: How Optometrists and Ophthalmologists Can Transform Geographic...

Geographic atrophy of the eye is a serious, progressive form of age-related macular degeneration (AMD) that can lead to irreversible vision loss. For many years, patients who asked “what is GA?” were told there was no effective treatment. Today, with FDA-approved therapies like Izervay are designed to slow disease progression, the responsibility falls on eye care professionals to identify geographic atrophy symptoms early and ensure patients enter the right care pathway. A clear referral process between optometrists and ophthalmologists is essential to deliver the best outcomes for patients with GA in eyes.